In multiple types of cancer, IL-17 expression has been correlated with tumor progression and is associated with poor prognosis in breast cancer (19) however, previous studies have also identified both pro- and anti- tumor function in the TME. The gene discussed is IL17A; the disease is breast carcinoma.